| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Zosano Pharma Corporation (NASDAQ: ZSAN)
ZSAN Technical Analysis
5
| As on 8th Jul 2022 ZSAN SHARE Price closed @ 0.30 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.87 & Strong Sell for SHORT-TERM with Stoploss of 1.27 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ZSANSHARE Price
| Open | 0.26 | Change | Price | % |
| High | 0.35 | 1 Day | -0.03 | -9.09 |
| Low | 0.26 | 1 Week | -0.02 | -6.25 |
| Close | 0.30 | 1 Month | -1.83 | -85.92 |
| Volume | 84252 | 1 Year | -0.76 | -71.70 |
| 52 Week High 3.25 | 52 Week Low 0.12 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ZSAN Daily Charts |
ZSAN Intraday Charts |
Whats New @ Bazaartrend |
ZSAN Free Analysis |
|
|
ZSAN Important Levels Intraday
| RESISTANCE | 0.47 |
| RESISTANCE | 0.42 |
| RESISTANCE | 0.38 |
| RESISTANCE | 0.35 |
| SUPPORT | 0.25 |
| SUPPORT | 0.22 |
| SUPPORT | 0.18 |
| SUPPORT | 0.13 |
ZSAN Forecast April 2024
| 4th UP Forecast | 4.44 |
| 3rd UP Forecast | 3.11 |
| 2nd UP Forecast | 2.29 |
| 1st UP Forecast | 1.47 |
| 1st DOWN Forecast | -0.87 |
| 2nd DOWN Forecast | -1.69 |
| 3rd DOWN Forecast | -2.51 |
| 4th DOWN Forecast | -3.84 |
ZSAN Weekly Forecast
| 4th UP Forecast | 0.82 |
| 3rd UP Forecast | 0.65 |
| 2nd UP Forecast | 0.55 |
| 1st UP Forecast | 0.45 |
| 1st DOWN Forecast | 0.15 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | -0.05 |
| 4th DOWN Forecast | -0.22 |
ZSAN Forecast2024
| 4th UP Forecast | 7.2 |
| 3rd UP Forecast | 4.99 |
| 2nd UP Forecast | 3.62 |
| 1st UP Forecast | 2.25 |
| 1st DOWN Forecast | -1.65 |
| 2nd DOWN Forecast | -3.02 |
| 3rd DOWN Forecast | -4.39 |
| 4th DOWN Forecast | -6.6 |
Zosano Pharma Corporation ( NASDAQ USA Symbol : ZSAN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ZSAN Business Profile
Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. Address: 34790 Ardentech Court, Fremont, CA, United States, 94555
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service